Domů › Rakovina (všechny typy) › Alabama › Birmingham
Klinické studie Rakovina (všechny typy) v Birmingham, AL
30 studií pro Rakovina (všechny typy) hledá účastníky v lokalitách v Birmingham a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Probíhá náborFáze 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Probíhá náborFáze 3
- UAB Medicine - UAB Hospital, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Probíhá náborFáze 3
- Quetzal Site 16, Birmingham
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Probíhá náborFáze 3
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Probíhá náborFáze 2/3
- University of Alabama Birmingham, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Probíhá náborFáze 2
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Probíhá náborFáze 1/2
- The University of Alabama at Birmingham ( Site 1005), Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Probíhá náborFáze 1
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- Children's Hospital of Alabama, Birmingham
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Probíhá náborFáze 2
- Childrens Hospital of Alabama, Birmingham
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- University of Alabama at Birmingham Cancer Center, Birmingham
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Probíhá náborFáze 2
- 004, Birmingham
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Probíhá náborFáze 1
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Probíhá nábor
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Probíhá náborFáze 1
- GSK Investigational Site, Birmingham
Childhood Cancer Survivor Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Probíhá nábor
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Multisite Implementation of COMPRENDO
Probíhá náborVítáni zdraví dobrovolníci
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Leading Healthy Eating and Activity Promotion Program
Probíhá náborVítáni zdraví dobrovolníci
- University of Alabama at Birmingham, Birmingham
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Probíhá nábor
- Children's of Alabama at Birmingham, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Probíhá náborFáze 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Probíhá nábor
- University of Alabama at Birmingham, Birmingham
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
Probíhá nábor
- University of Alabama at Birmingham, Birmingham
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Probíhá náborObservační studie
- Alabama Oncology, Birmingham
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
Probíhá nábor
- The Kirklin Clinic, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
Probíhá náborObservační studie
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Probíhá nábor
- University of Alabama at Brimingham, Birmingham
Making Healthy Habits Stick
Probíhá nábor
- University of Alabama at Birmingham, Birmingham
Studie Rakovina (všechny typy) v jiných městech
- Houston, TX121 studií
- New York City, NY110 studií
- Boston, MA86 studií
- Los Angeles, CA73 studií
- Nashville, TN65 studií
- Philadelphia, PA59 studií
- Durham, NC58 studií
- Washington, DC58 studií
- Chicago, IL51 studií
- Seattle, WA49 studií
- Atlanta, GA49 studií
- Arlington, VA48 studií
Další studie v Birmingham
- Rakovina prsu24 studií
- Obesity23 studií
- Rakovina vaječníků23 studií
- Nemalobuněčný plicní karcinom22 studií
- Akutní myeloidní leukemie21 studií
- Mnohočetný myelom18 studií
- CHOPN17 studií
- Kardiovaskulární onemocnění17 studií
- Nadváha16 studií
- Rakovina endometria16 studií
- Diabetes mellitus 2. typu16 studií
- Cystická fibróza16 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.